Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and

Scott Poh1,2, Venkatesh Chelvam1,3, Philip S Low1

  • 11Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.

Abstract

Insights

Nanoparticle delivery agents accumulate better in inflammatory sites than solid tumors. This suggests nanomedicines may be more effective for treating inflammatory diseases than cancer.

Area of Science:

  • Nanomedicine
  • Oncology
  • Immunology

Background:

  • Nanomedicine research heavily focuses on cancer diagnosis and treatment.
  • Solid tumors' dense extracellular matrix hinders nanoparticle penetration.
  • This raises questions about nanomedicines' optimal applications in oncology.

Purpose of the Study:

  • To compare nanoparticle uptake in tumors versus inflammatory lesions.
  • To investigate the potential of nanomedicines beyond oncology.

Main Methods:

  • Utilized folate-conjugated liposomes for targeted delivery.
  • Compared liposome uptake in folate receptor-expressing tumors and inflammatory lesions within the same mouse model.

Main Results:

  • Both targeted and nontargeted liposomes showed higher accumulation at inflammatory sites compared to solid tumors.
  • Demonstrated differential accumulation based on lesion type, not solely targeting.

Conclusions:

  • Nanosized agents may be more suitable for diagnosing and treating inflammatory and autoimmune diseases.
  • Current nanomedicine applications might be better directed away from solid tumors.
  • Suggests a paradigm shift in nanomedicine research focus.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
130
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
125
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
314